title: Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
authors.affiliation: Department of Dermato-allergology, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.
authors.forename: Nannie
authors.initials: N
authors.lastname: Bangsgaard
authors.affiliation: Department of Dermato-allergology, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.
authors.forename: Louise A N
authors.initials: LA
authors.lastname: Fischer
authors.affiliation: Department of Dermato-allergology, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.
authors.forename: Claus
authors.initials: C
authors.lastname: Zachariae
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects*; D000068438:Brimonidine Tartrate / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012393:Rosacea / Q000188:drug therapy*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000068438:Brimonidine Tartrate
keywords: Mirvaso®; brimonidine tartrate; case report; contact allergy; rosacea; sensitization